Clinical Trial Update: Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) [Phase 3]

View source ↗

Summary

Phase 3 follow-up study in Japan evaluating subcutaneous immune globulin for patients requiring IgG replacement therapy; the trial completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Deficiency Disorder

Drugs mentioned

• Hizentra (subcutaneous immunoglobulin (IgG))

Snippet

Sponsor: CSL Behring | Conditions: Primary Immune Deficiency Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-04-09